Organogenesis Holdings Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $93.7M | $135.6M | $103.8M | $102.5M | $113.9M | $84.4M | $60.4M | $21.4M |
| Accounts Receivable | $217.5M | $109.9M | $82.0M | $89.5M | $82.5M | $56.8M | $39.4M | $34.1M |
| Inventory | $29.6M | $26.2M | $28.3M | $24.8M | $25.0M | $27.8M | $22.9M | $13.3M |
| Total Current Assets | $362.2M | $285.9M | $225.0M | $222.6M | $227.0M | $174.3M | $125.6M | $71.1M |
| Property, Plant & Equipment | $103.7M | $89.1M | $116.2M | $102.5M | $79.2M | $55.8M | $47.2M | $39.6M |
| Goodwill | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $25.5M | $25.5M |
| Intangible Assets (Excl. Goodwill) | $9.1M | $12.5M | $15.9M | $20.8M | $25.7M | $30.6M | $20.8M | $26.1M |
| Total Assets | $598.7M | $497.9M | $460.0M | $449.4M | $443.3M | $290.2M | $220.7M | $163.7M |
| Liabilities | ||||||||
| Accounts Payable | $31.9M | $28.9M | $30.7M | $32.3M | $29.3M | $23.4M | $28.4M | $19.2M |
| Total Current Liabilities | $100.1M | $77.5M | $80.5M | $75.0M | $82.7M | $68.2M | $59.9M | $56.1M |
| Long-Term Debt | — | — | $66.6M | $71.3M | $74.1M | $70.0M | $49.6M | — |
| Total Liabilities | $164.8M | $112.6M | $181.4M | $183.7M | $201.9M | $148.4M | $165.1M | $116.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-3.1M | $-40.1M | $-41.0M | $-45.3M | $-60.8M | $-155.0M | $-171.0M | $-130.2M |
| Total Stockholders' Equity | $300.1M | $262.9M | $278.7M | $265.7M | $241.3M | $141.8M | $52.0M | $39.9M |